Published in J Biol Chem on March 03, 2000
Involvement of mast cells in eosinophilic esophagitis. J Allergy Clin Immunol (2010) 1.92
p21-activated kinase regulates mast cell degranulation via effects on calcium mobilization and cytoskeletal dynamics. Blood (2009) 1.53
IFN-gamma-induced IDO and WRS expression in microglia is differentially regulated by IL-4. Glia (2007) 0.90
The role of serine/threonine protein phosphatases in exocytosis. Biochem J (2003) 0.89
Protein phosphatases 1 and 2A transiently associate with myosin during the peak rate of secretion from mast cells. Mol Biol Cell (2002) 0.86
A Pak1-PP2A-ERM signaling axis mediates F-actin rearrangement and degranulation in mast cells. Exp Hematol (2012) 0.83
Anti-CD44 induces apoptosis in T lymphoma via mitochondrial depolarization. J Cell Mol Med (2009) 0.82
Protein phosphatase 2A is regulated by protein kinase Cα (PKCα)-dependent phosphorylation of its targeting subunit B56α at Ser41. J Biol Chem (2013) 0.80
The role of the Annexin-A1/FPR2 system in the regulation of mast cell degranulation provoked by compound 48/80 and in the inhibitory action of nedocromil. Int Immunopharmacol (2016) 0.77
Involvement of serine/threonine protein phosphatases sensitive to okadaic acid in restraint stress-induced hyperlocomotion in cocaine-sensitized mice. Br J Pharmacol (2006) 0.76
Effects of the tumour promoter okadaic acid on intracellular protein phosphorylation and metabolism. Nature (1989) 4.27
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA (1999) 3.69
Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem (2001) 2.56
Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J Infect Dis (1998) 2.11
Location and function of three sites phosphorylated on rat acetyl-CoA carboxylase by the AMP-activated protein kinase. Eur J Biochem (1990) 1.83
Calcineurin inhibition of dynamin I GTPase activity coupled to nerve terminal depolarization. Science (1994) 1.83
Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans. Infect Immun (1998) 1.42
Mixed endocrine pancreatic tumors producing several peptide hormones. Am J Pathol (1975) 1.41
Distribution and properties of glucagon immunoreactivity in the digestive tract of various mammals: an immunohistochemical and immunochemical study. Histochemistry (1975) 1.27
Outer membrane protein vesicle vaccines for meningococcal disease. Methods Mol Med (2001) 1.23
The applicability of chimney grafts in the aortic arch. J Cardiovasc Surg (Torino) (2009) 1.20
Human opsonins induced during meningococcal disease recognize outer membrane proteins PorA and PorB. Infect Immun (1999) 1.17
Functional assays for evaluation of serogroup B meningococcal structures as mediators of human opsonophagocytosis. J Immunol Methods (1997) 1.11
The Fat1 cadherin is overexpressed and an independent prognostic factor for survival in paired diagnosis-relapse samples of precursor B-cell acute lymphoblastic leukemia. Leukemia (2011) 1.08
Use of okadaic acid to inhibit protein phosphatases in intact cells. Methods Enzymol (1991) 1.08
Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease. Vaccine (1999) 1.07
Multiple interactions within the AKAP220 signaling complex contribute to protein phosphatase 1 regulation. J Biol Chem (2001) 1.07
Could the mechanisms of bariatric surgery hold the key for novel therapies? report from a Pennington Scientific Symposium. Obes Rev (2011) 1.02
Comparison of functional immune responses in humans after intranasal and intramuscular immunisations with outer membrane vesicle vaccines against group B meningococcal disease. Vaccine (2003) 1.02
Outer membrane vesicles from group B meningococci are strongly immunogenic when given intranasally to mice. Vaccine (1999) 1.01
Antor-pyloric gastrinoma associated with pancreatic nesidioblastosis and proliferation of islets. Virchows Arch A Pathol Pathol Anat (1973) 1.00
A nasal whole-cell pertussis vaccine can induce strong systemic and mucosal antibody responses which are not enhanced by cholera toxin. Vaccine (1997) 0.96
A new methodological approach to the evaluation of quality of life in postmenopausal women. Maturitas (1992) 0.95
Pancreatic glucagon response to an ordinary meal. Scand J Gastroenterol (1975) 0.93
Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstet Gynecol Scand (1985) 0.93
Protein phosphorylation and calcium uptake into rat forebrain synaptosomes: modulation by the sigma ligand, 1,3-ditolylguanidine. J Neurochem (1997) 0.92
Induction of antigen-specific T cell responses in human volunteers after intranasal immunization with a whole-cell pertussis vaccine. Vaccine (2000) 0.91
Localization of glucagonomas by catheterization of the pancreatic veins and with glucagon assay. Surg Gynecol Obstet (1977) 0.89
Towards a nasal vaccine against meningococcal disease, and prospects for its use as a mucosal adjuvant. Dev Biol Stand (1998) 0.88
A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers. J Med Microbiol (2000) 0.88
Regulation of neuronal PP1 and PP2A during development. Methods Mol Biol (1998) 0.87
Antigen-specific T-cell responses in humans after intranasal immunization with a meningococcal serogroup B outer membrane vesicle vaccine. Infect Immun (1999) 0.86
Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine. Dev Biol Stand (1998) 0.86
Modulation of the phosphorylation and activity of calcium/calmodulin-dependent protein kinase II by zinc. J Neurochem (2000) 0.86
Immunogenicity studies with a genetically engineered hexavalent PorA and a wild-type meningococcal group B outer membrane vesicle vaccine in infant cynomolgus monkeys. Vaccine (2000) 0.86
On the sympathetic innervation to the cat's liver and its role for hepatic glucose release. Acta Physiol Scand (1980) 0.85
Effects in vitro of progesterone and two 5 alpha-reduced progestins, 5 alpha-pregnane-3,20-dione and 5 alpha-pregnane-3 alpha-ol-20-one, on contracting human myometrium at term. Acta Obstet Gynecol Scand (1992) 0.84
Developmental regulation of protein phosphatase types 1 and 2A in post-hatch chicken brain. Neurochem Res (1998) 0.84
Various local hemostatic agents with different modes of action; an in vivo comparative randomized vascular surgical experimental study. Eur J Vasc Endovasc Surg (2006) 0.84
Inactivated meningococci and pertussis bacteria are immunogenic and act as mucosal adjuvants for a nasal inactivated influenza virus vaccine. Vaccine (2000) 0.83
Meningococcal outer membrane vesicle vaccine given intranasally can induce immunological memory and booster responses without evidence of tolerance. Infect Immun (2001) 0.83
Failure of somatostatin to eliminate the glucagon release induced by baroreceptor unloading in the cat. Acta Physiol Scand (1978) 0.83
Pituitary adenylate cyclase-activating polypeptide stimulates insulin and glucagon secretion in humans. J Clin Endocrinol Metab (1997) 0.83
The role of the adrenergic innervation to the pancreatic islets in the control of insulin release during exercise in man. Pflugers Arch (1979) 0.83
Oral spray immunization may be an alternative to intranasal vaccine delivery to induce systemic antibodies but not nasal mucosal or cellular immunity. Scand J Immunol (2006) 0.82
Balloon control for ruptured AAAs: when and when not to use? J Cardiovasc Surg (Torino) (2014) 0.82
Protein phosphatase activity in cyanobacteria: consequences for microcystin toxicity analysis. Toxicon (1993) 0.81
Effects of adrenergic blockade on the release of insulin, glucagon and somatostatin from the pancreas in response to splanchnic nerve stimulation in cats. Acta Physiol Scand (1982) 0.81
Outer membrane vesicles from Neisseria meningitidis: effects on cytokine production in human whole blood. Cytokine (2001) 0.80
A fibroblast elongation factor purified from colon carcinoma cells shares sequence identity with TIMP-1. Biochem Biophys Res Commun (1995) 0.80
Emergency intervention for thrombosed popliteal artery aneurysm: can the limb be salvaged? J Cardiovasc Surg (Torino) (2007) 0.80
Tyrosine hydroxylase phosphorylation in digitonin-permeabilized bovine adrenal chromaffin cells: the effect of protein kinase and phosphatase inhibitors on Ser19 and Ser40 phosphorylation. J Neurochem (1997) 0.79
Immunohistochemical demonstration of glucagon in an A 2 -cell carcinoma. Experientia (1973) 0.79
Perioperative haemorrhage in endovascular abdominal aneurysm repair affects outcome. Eur J Vasc Endovasc Surg (2013) 0.79
The relation between catecholamines, glucagon and pancreatic polypeptide during hypoglycaemia in man. Acta Endocrinol (Copenh) (1981) 0.78
Bacteria-derived particles as adjuvants for non-replicating nasal vaccines. Adv Drug Deliv Rev (2001) 0.78
Endometrial findings following curettage in 2018 women according to age and indications. Ann Chir Gynaecol (1983) 0.77
Tyrosine hydroxylase phosphorylation in bovine adrenal chromaffin cells: the role of intracellular Ca2+ in the histamine H1 receptor-stimulated phosphorylation of Ser8, Ser19, Ser31, and Ser40. J Neurochem (1995) 0.77
Influence of peptides on anorectal function. Ann Med (1990) 0.77
Phosphorylation of branched-chain 2-oxo acid dehydrogenase complex in isolated hepatocytes. Biochem Biophys Res Commun (1987) 0.77
Outer membrane vesicles from Neisseria meningitidis: effects on tissue factor and plasminogen activator inhibitor-2 production in human monocytes. Thromb Res (2001) 0.77
Performance evaluation of the Abbott CELL-DYN Emerald for use as a bench-top analyzer in a research setting. Int J Lab Hematol (2012) 0.77
Anhydride modified cantharidin analogues. Is ring opening important in the inhibition of protein phosphatase 2A? Eur J Med Chem (2000) 0.77
Diurnal variations in thyrotropin, prolactin and cortisol during human pregnancy. Gynecol Obstet Invest (1989) 0.77
Lack of suppression of insulin secretion by exercise in patients with insulinoma. Clin Endocrinol (Oxf) (1981) 0.77
A liquid mixed meal or exogenous glucagon-like peptide 1 (GLP-1) do not alter plasma leptin concentrations in healthy volunteers. Acta Diabetol (1997) 0.76
Percutaneous estrogen therapy--a semi-quantitative histologic study of the abdominal skin. Acta Obstet Gynecol Scand (1982) 0.75
Endometrial effects of a continuous percutaneous oestrogen/low dose oral progestogen regimen for climacteric complaints. Maturitas (1987) 0.75
[Glucagon-producing endocrine pancreas tumors. Symptoms, diagnosis, localization, therapy and follow-up]. Chirurg (1979) 0.75
Serum levels of unbound 17 beta-oestradiol during oral and percutaneous postmenopausal replacement therapy. Br J Obstet Gynaecol (1984) 0.75
Percutaneous estrogen therapy. Endometrial response and metabolic effects. Acta Obstet Gynecol Scand Suppl (1983) 0.75
Differential regulation of membrane receptors sensitive to histamine (H2-type), isoproterenol (beta 2-type) and glucagon-like peptides by the somatostatin analogue Sandostatin in rat gastric glands. Agents Actions (1989) 0.75
[Gynecologic curettage--evaluation of the benefits and costs]. Lakartidningen (1982) 0.75
[Tuberculosis in adults as the cause of death, autopsy findings]. Duodecim (1969) 0.75
[Postoperative respiratory failure after parenteral administration of analgesics]. Lakartidningen (1987) 0.75
Altered concentrations of gastrin-releasing polypeptide and somatostatin in fundic and duodenal bulb mucosa of patients with duodenal ulcer disease. Am J Gastroenterol (1987) 0.75
Role of the sympatho-adrenal system in the control of endocrine pancreas during haemorrhage in cats. Eur Surg Res (1979) 0.75
Percutaneous estrogen replacement therapy. Effects on circulating estrogens, gonadotropins and prolactin. Acta Obstet Gynecol Scand (1983) 0.75
Cellular morphometric analysis of the postmenopausal endometrium during treatment with percutaneous estradiol-17 beta with and without oral gestagen. Acta Obstet Gynecol Scand (1983) 0.75
[Percutaneous estrogen treatment instead of oral treatment--a alternative in preventing side effects?]. Lakartidningen (1986) 0.75
Pirenzepine depresses plasma noradrenaline in duodenal ulcer patients. Acta Chir Scand Suppl (1984) 0.75
Effect of low molecular weight heparin, dextran and their combinations on experimental venous thrombosis in rabbits. Thromb Haemost (1994) 0.75
Serum estrogen levels after topic application of estradiol-17 beta on two different cutaneous areas. Acta Obstet Gynecol Scand (1987) 0.75
[Glucagonoma--symptoms, diagnosis, localization, therapy and follow-up]. Lakartidningen (1978) 0.75
Endometrial response following percutaneous estrogen replacement therapy. A morphometric investigation. Acta Obstet Gynecol Scand (1983) 0.75
Tuberculosis--diagnosed and undiagnosed--as a cause of death. Autopsy observations. Scand J Respir Dis (1971) 0.75
Metabolic and hormonal adjustments during hemorrhage in cats after interference with the sympatho-adrenal system. Acta Physiol Scand (1982) 0.75
[A study of hypnotic treatment in levator ani spasm syndrome]. Duodecim (1979) 0.75
A comparison of liver protein induction in postmenopausal women during oral and percutaneous oestrogen replacement therapy. Br J Obstet Gynaecol (1983) 0.75
Plasma glucagon in acute and chronic pancreatitis. World J Surg (1978) 0.75
[Estrogen treatment and liver protein synthesis]. Duodecim (1984) 0.75
Effects of physiological increases in plasma noradrenaline on the human endocrine pancreas. J Endocrinol Invest (1989) 0.75
Selective catheterization of the pancreatic vein for radioimmunoassay in glucagon-secreting carcinoma of the pancreas. Radiology (1976) 0.75
Percutaneous oestrogen therapy opposed by lynestrenol or natural progesterone--effects on circulating oestrogens, FSH, sex hormone binding globulin and pregnancy zone protein. Maturitas (1983) 0.75
Conservative treatment of ureteric stones. Ureteric stones--surgical intervention. Ann Chir Gynaecol (1985) 0.75
OPT-reactive cells and gastrin cells in the digestive tract of the chicken. Agents Actions (1974) 0.75
Ultrastructural identification of cells storing pancreatic-type glucagon in dog stomach. Histochemistry (1976) 0.75
Endometrial response in post-menopausal women during treatment with percutaneous 17 beta-oestradiol opposed by oral progesterone. Maturitas (1986) 0.75
[Percutaneous estrogen replacement therapy. An alternative for oral treatment]. Duodecim (1983) 0.75